Human Placental Protein Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented By Type (Hydrolyzed Human Placental Protein, Human Placental Enzymes), By Application (Tumor Markers, Skin Care Products), and Geography.

Market Snapshot

human placental protein market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: <5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Human Placental Protein Market is expected to register a CAGR of around 5% during the forecast period. Rising use of placental protein in cosmetics and medication to treat menopause is among the key factor triggering the growth of the human placental protein market. For instance, several products are in the human placental market which is promoting the revenue growth, Melsmon pharmaceuticals are producing pharmaceutical-grade placenta which is used for treating menopause. In addition, Japan Bio Products has Laennec which treats chronic hepatitis and another company Alber David has Inj.Placentrex. (wound healer).

The increase in R&D investments in healthcare coupled with the introduction of human placental protein in pseudo-medicines will create lucrative opportunities in the human placental protein market.

However, prolonged use of human placental proteins can cause skin dryness which hampers the market.

Scope of the Report

As per the scope, Human placental protein includes protein derived from human placentas used in several applications such as luteotropic, lactogenic, cosmetics and growth-promoting action. Human Placental Protein Market is segmented By Type, Application, and Geography.

By Type
Hydrolyzed Human Placental Protein
Human Placental Enzymes
Others
By Application
Tumor markers
Life sciences
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Skin Care Products in Human Placental Protein Segment is Expected to Hold Significant Market Share

Skin Care Products are expected to dominate the global human placental protein market in the forecast period. This can be attributed to the rising prevalence of cosmetics products among the targeted population and the increasing number of menopause population. As the placenta connects developing fetus to the uterine wall to all nutrients uptake, thermoregulation, fighting against internal infection and produce hormones to support pregnancy, which makes placenta protein highly nutritious and thus it further hydrolyzed and use it for many skincare products and hair care treatments.

In addition, with the increasing aging population worldwide, the human placental protein extract has been extensively used for anti-aging therapy and is promoting the growth of the overall market.

Aging Population - 2

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Human Placental Protein market attributing to an increasingly aging population with a higher rate of menopause population in this region. According to the National Institute of Health, approximately 1.3 million women become menopausal each year and 5% experience early menopause in the United States. This is leading to the adoption of placental extract for treating menopausal, thus promote the growth of the human placental protein market. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

human placental geography.png

Competitive Landscape

The market studied is moderately competitive and most of the companies operating in the market are the local players from various countries. Some of the companies which are currently getting the attention in the market are JAPAN BIO PRODUCTS Co., Ltd., VWR International, Takara Bio Inc, Abcam plc, Kamiya Biomedical Co, Scripps Laboratories, Lee BioSolutions and elabscience.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing use of Cosmetics Products

      2. 4.2.2 Increasing Ageing Population

    3. 4.3 Market Restraints

      1. 4.3.1 Adverse Effects

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Hydrolyzed Human Placental Protein

      2. 5.1.2 Human Placental Enzymes

      3. 5.1.3 Others

    2. 5.2 By Application

      1. 5.2.1 Tumor markers

      2. 5.2.2 Life sciences

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 JAPAN BIO PRODUCTS Co., Ltd.

      2. 6.1.2 VWR International

      3. 6.1.3 Takara Bio Inc

      4. 6.1.4 Abcam plc

      5. 6.1.5 Kamiya Biomedical Co.

      6. 6.1.6 Scripps Laboratories

      7. 6.1.7 Lee BioSolutions

      8. 6.1.8 elabscience

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of <5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Takara Bio Inc, VWR International, Scripps Laboratories, Lee BioSolutions, JAPAN BIO PRODUCTS Co. are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!